心脏问题:与瘤基因成非小细胞肺癌的向治疗相关的心脏毒性
Sara Torresan1,2, Martina Bortolot1,2, Elisa De Carlo1
1Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico, 33081 Aviano, Italy.
International journal of molecular sciences
|January 25, 2025
概括
向疗法可以提高非小细胞肺癌 (NSCLC) 的存活率,但会带来特定的心脏毒性风险. 管理这需要平衡有效的癌症治疗与患者的安全和生活质量.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 包括氨酸激酶抑制剂在内的向疗法已经改变了非小细胞肺癌 (NSCLC) 治疗,改善了反应率和整体存活率.
- 虽然有效,但这些疗法具有独特的不良事件,特别是心脏毒性,由于患者的并发症,这些不良事件可能无法从临床试验数据中完全明显.
- 与NSCLC的向治疗相关的心脏毒性是一个新兴的问题,需要仔细管理.
研究的目的:
- 审查目前关于与用于非小细胞肺癌的向治疗相关的心脏毒性知识.
- 总结用于NSCLC的各种向药物的特定安全概况.
- 强调在接受向治疗的NSCLC患者心脏毒性管理的重要性.
主要方法:
- 对针对NSCLC的向治疗研究的文献综述.
- 对不良事件概况的分析,重点关注心脏毒性.
- 综合有关心脏毒性的管理和预防的信息.
主要成果:
- 针对NSCLC的向疗法具有独特的安全性,心脏毒性是一个重大问题.
- 心脏毒性的现实频率和范围可能超过临床试验观察结果.
- 管理策略必须平衡瘤治疗疗效与减轻心血管风险.
结论:
- 心脏毒性是接受向治疗的NSCLC患者管理的一个关键考虑因素.
- 积极的监测和管理对于维护生活质量和预防严重事件至关重要.
- 需要进一步的研究,以充分理解和减轻新型NSCLC治疗的心血管风险.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:26Heart Failure Drugs: Inotropic Agents
507
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
507
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:27Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466